Search results

  1. 1.
    0306792 - ÚMG 2009 RIV GB eng J - Journal Article
    Manning, Jasper - Indrová, Marie - Lubyová, B. - Přibylová, Hana - Bieblová, Jana - Hejnar, Jiří - Šímová, Jana - Jandlová, Táňa - Bubeník, Jan - Reiniš, Milan
    Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours.
    [Indukce povrchové exprese MHC molekul I. třídy a epigenetická aktivace složek antigen prezentující dráhy na myším modelu nádorů asociovaných s lidským papillomavirem HPV16.]
    Immunology. Roč. 123, č. 2 (2008), s. 218-227. ISSN 0019-2805. E-ISSN 1365-2567
    R&D Projects: GA ČR GA301/04/0492; GA ČR GA301/07/1410
    EU Projects: European Commission(XE) 18933 - CLINIGENE
    Grant - others:Liga proti rakovině, Praha(CZ) -
    Institutional research plan: CEZ:AV0Z50520514
    Keywords : major hiostocompatibility system class I * epigenetics * HPV 16
    Subject RIV: EB - Genetics ; Molecular Biology
    Impact factor: 3.432, year: 2008
    Permanent Link: http://hdl.handle.net/11104/0159721
     
     
  2. 2.
    0191680 - UMG-J 20033195 RIV GR eng J - Journal Article
    Mikyšková, Romana - Indrová, Marie - Šímová, Jana - Jandlová, Táňa - Bieblová, Jana - Jinoch, P. - Bubeník, Jan - Vonka, V.
    Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: cytokine and gene therapy with IL-2 and GM-CSF.
    International Journal of Oncology. Roč. 24, č. 1 (2004), s. 161-167. ISSN 1019-6439. E-ISSN 1791-2423
    R&D Projects: GA MZd NC7148; GA MZd NC7552; GA ČR GA301/01/0985
    Institutional research plan: CEZ:AV0Z5052915
    Keywords : HPV16 * gene therapy * minimal residual tumour disease
    Subject RIV: FD - Oncology ; Hematology
    Impact factor: 3.056, year: 2004
    Permanent Link: http://hdl.handle.net/11104/0087418
     
     
  3. 3.
    0191666 - UMG-J 20033177 RIV CZ eng J - Journal Article
    Šímová, Jana - Mikyšková, Romana - Vonka, V. - Bieblová, Jana - Bubeník, Jan - Jandlová, Táňa
    MHC class I+ and class I(-)HPV16-associated tumours expressing the E7 oncoprotein do not cross-react in immunization/challenge experiments.
    Folia Biologica. Roč. 2003, č. 49 (2003), s. 230-234. ISSN 0015-5500. E-ISSN 0015-5500
    Institutional research plan: CEZ:AV0Z5052915
    Keywords : HPV 16 * MHC class I expression * tumour vaccines
    Subject RIV: EB - Genetics ; Molecular Biology
    Impact factor: 0.527, year: 2003
    Permanent Link: http://hdl.handle.net/11104/0087404
     
     
  4. 4.
    0191665 - UMG-J 20033176 RIV CZ eng J - Journal Article
    Šímová, Jana - Bieblová, Jana - Jandlová, Táňa - Bubeník, Jan
    Immunotherapy of HPV-16-associated tumours with tumour cell line/dendritic cell line (TC-1/DC2.4) hybrid vaccines.
    Folia Biologica. Roč. 2003, č. 49 (2003), s. 203-206. ISSN 0015-5500. E-ISSN 0015-5500
    Institutional research plan: CEZ:AV0Z5052915
    Keywords : HPV16 * dendritic cells * fusion
    Subject RIV: EB - Genetics ; Molecular Biology
    Impact factor: 0.527, year: 2003
    Permanent Link: http://hdl.handle.net/11104/0087403
     
     
  5. 5.
    0191663 - UMG-J 20033174 RIV CZ eng J - Journal Article
    Indrová, Marie - Mikyšková, Romana - Jandlová, Táňa - Vonka, V. - Bubeník, Jan - Bieblová, Jana
    Adjuvant cytokine treatment of minimal residual disease after surgical therapy in mice carrying HPV16-associated tumours: Cytolytic activity of spleen cells from tumour regressors.
    Folia Biologica. Roč. 2003, č. 49 (2003), s. 217-222. ISSN 0015-5500. E-ISSN 0015-5500
    Institutional research plan: CEZ:AV0Z5052915
    Keywords : HPV16 * gene therapy * IL-2
    Subject RIV: EB - Genetics ; Molecular Biology
    Impact factor: 0.527, year: 2003
    Permanent Link: http://hdl.handle.net/11104/0087401
     
     
  6. 6.
    0191662 - UMG-J 20033173 RIV GR eng J - Journal Article
    Indrová, Marie - Bubeník, Jan - Mikyšková, Romana - Vonka, V. - Šmahel, M. - Žák, R. - Šímová, Jana - Bieblová, Jana - Mendoza, Luis - Jandlová, Táňa
    Tumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class I- tumours of HPV16 origin.
    International Journal of Oncology. Roč. 2002, č. 20 (2002), s. 643-646. ISSN 1019-6439. E-ISSN 1791-2423
    Institutional research plan: CEZ:AV0Z5052915
    Keywords : HPV16, IL-2 * tumour vaccines * gene therapy
    Subject RIV: EB - Genetics ; Molecular Biology
    Impact factor: 2.931, year: 2002
    Permanent Link: http://hdl.handle.net/11104/0087400
     
     
  7. 7.
    0191583 - UMG-J 20033050 RIV GR eng J - Journal Article
    Mendoza, Luis - Bubeník, Jan - Šímová, Jana - Jandlová, Táňa - Vonka, V. - Mikyšková, Romana
    Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV16-associated tumours.
    International Journal of Oncology. Roč. 23, č. 1 (2003), s. 243-247. ISSN 1019-6439. E-ISSN 1791-2423
    R&D Projects: GA MZd NC7148; GA ČR GA301/01/0985; GA AV ČR IAA5052203
    Grant - others:Liga proti rakovině(CZ) -
    Institutional research plan: CEZ:AV0Z5052915
    Keywords : HPV 16 * dendritic cells * residual tumour disease
    Subject RIV: FD - Oncology ; Hematology
    Impact factor: 2.536, year: 2003
    Permanent Link: http://hdl.handle.net/11104/0087325
     
     
  8. 8.
    0191582 - UMG-J 20033049 RIV GR eng J - Journal Article
    Indrová, Marie - Bubeník, Jan - Mikyšková, Romana - Mendoza, Luis - Šímová, Jana - Bieblová, Jana - Jandlová, Táňa - Jinoch, P. - Šmahel, M. - Vonka, V. - Pajtasz-Piasecka, E.
    Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    International Journal of Oncology. Roč. 22, č. 3 (2003), s. 691-695. ISSN 1019-6439. E-ISSN 1791-2423
    R&D Projects: GA MZd NC7148; GA ČR GA301/00/0114; GA ČR GA301/01/0985; GA AV ČR IAA5052203; GA AV ČR IAA7052002
    Grant - others:KBN(PL) P04A12314; Liga proti rakovině(CZ) -
    Institutional research plan: CEZ:AV0Z5052915
    Keywords : chemotherapy-induced residual tumour disease * immunotherapy * HPV16-associated tumours
    Subject RIV: FD - Oncology ; Hematology
    Impact factor: 2.536, year: 2003
    Permanent Link: http://hdl.handle.net/11104/0087324
     
     
  9. 9.
    0191581 - UMG-J 20033048 RIV CZ eng J - Journal Article
    Mikyšková, Romana - Bieblová, Jana - Šímová, Jana - Indrová, Marie - Jandlová, Táňa - Vonka, V. - Šmahel, M. - Bubeník, Jan - Mendoza, Luis
    Local IFN-gamma therapy of HPV16-associated tumours.
    Folia Biologica. Roč. 49, č. 1 (2003), s. 26-32. ISSN 0015-5500. E-ISSN 0015-5500
    R&D Projects: GA MZd NC7148; GA MZd NC5900; GA ČR GA301/01/0985
    Grant - others:GA CZ(CZ) Liga proti rakovině
    Institutional research plan: CEZ:AV0Z5052915
    Keywords : MHC class I * IFN-gamma * HPV16
    Subject RIV: FD - Oncology ; Hematology
    Impact factor: 0.527, year: 2003
    Permanent Link: http://hdl.handle.net/11104/0087323
     
     
  10. 10.
    0191464 - UMG-J 20023041 RIV CZ eng J - Journal Article
    Mendoza, Luis - Bubeník, Jan - Šímová, Jana - Korb, Jan - Bieblová, Jana - Vonka, V. - Indrová, Marie - Mikyšková, Romana - Jandlová, Táňa
    Tumour-inhibitory effects of dendritic cells administered at the site of HPV 16-induced neoplasms.
    Folia Biologica. Roč. 48, č. 3 (2002), s. 114-119. ISSN 0015-5500. E-ISSN 0015-5500
    R&D Projects: GA MZd NC7148; GA ČR GA301/00/0114; GA AV ČR IAA7052002; GA AV ČR IAA5052203
    Institutional research plan: CEZ:AV0Z5052915
    Keywords : HPV 16 * dendritic cells * adjuvant therapy
    Subject RIV: EB - Genetics ; Molecular Biology
    Impact factor: 0.615, year: 2002
    Permanent Link: http://hdl.handle.net/11104/0087216
     
     

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.